We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.025 | -3.03% | 0.80 | 0.75 | 0.85 | 0.825 | 0.80 | 0.825 | 516,619 | 10:33:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
TIDMN4P
RNS Number : 2255W
N4 Pharma PLC
10 November 2017
10(th) November 2017
N4 Pharma plc (the "Company")
Notification of Transaction by Directors/PDMRs
The Company was notified on 10(th) November 2017 that a Person Discharging Management Responsibilities ("PDMR"), had purchased shares in the Company as set out below. Following this purchase, Nigel Theobald now has a total beneficial interest in 12,255,233 Ordinary Shares, representing 16.4% of the issued share capital of the Company.
The Company's share capital consists of 74,714,285 Ordinary Shares with voting rights.
1 Details of the person discharging managerial responsibilities/person closely associated ----- -------------------------------------------------------------- a) Name Nigel Theobald ----- ----------------------------- ------------------------------- 2 Reason for the notification ----- -------------------------------------------------------------- a) Position/status CEO and Director ----- ----------------------------- ------------------------------- b) Initial notification/ Initial notification Amendment ----- ----------------------------- ------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ----- -------------------------------------------------------------- a) Name N4 Pharma Plc ----- ----------------------------- ------------------------------- b) LEI 213800I841D2RKMFK955 ----- ----------------------------- ------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ----- -------------------------------------------------------------- a) Description Oridinary shares BGP 0.0004 of the financial ISIN code GB00BYW8QM32 instrument, type of instrument Identification code ----- ----------------------------- ------------------------------- b) Nature of the Direct purchase of shares transaction ----- ----------------------------- ------------------------------- c) Price(s) and Price volume volume(s) ----- ----------------------------- ------------------- ---------- GBP0.07925 56,656 ------------------------------------------------------- ---------- d) Aggregated n/a information - Aggregated price - Aggregated volume - Aggregated total ----- ----------------------------- ------------------------------- e) Date of the 10(th) November 2017 transaction ----- ----------------------------- ------------------------------- f) Place of the London Stock Exchange, AIM transaction ----- ----------------------------- ------------------------------- g) Additional Information ----- -------------------------------------------------- ----------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAKFEFEDXFFF
(END) Dow Jones Newswires
November 10, 2017 11:04 ET (16:04 GMT)
1 Year N4 Pharma Chart |
1 Month N4 Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions